Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK

Emery, P orcid.org/0000-0002-7429-8482, Van Keep, M, Beard, S et al. (6 more authors) (2018) Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK. PharmacoEconomics, 36 (8). pp. 1015-1027. ISSN 1170-7690

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Dates:
  • Accepted: 10 May 2018
  • Published (online): 25 May 2018
  • Published: August 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 25 Jul 2018 11:52
Last Modified: 28 Feb 2019 10:40
Status: Published
Publisher: Springer / Adis
Identification Number: https://doi.org/10.1007/s40273-018-0675-9

Export

Statistics